142 related articles for article (PubMed ID: 25404476)
1. Flow Cytometric Quantification of Intraperitoneal Free Tumor Cells is a Useful Biomarker in Gastric Cancer Patients with Peritoneal Metastasis.
Kitayama J; Emoto S; Yamaguchi H; Ishigami H; Onoyama H; Yamashita H; Seto Y; Matsuzaki K; Watanabe T
Ann Surg Oncol; 2015 Jul; 22(7):2336-42. PubMed ID: 25404476
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric quantification of intraperitoneal free tumor cells in patients with peritoneal metastasis.
Kitayama J; Emoto S; Yamaguchi H; Ishigami H; Kamei T; Yamashita H; Seto Y; Matsuzaki K; Watanabe T
Cytometry B Clin Cytom; 2014 Jan; 86(1):56-62. PubMed ID: 24115348
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric quantification of intraperitoneal free tumor cells (FTC) in patients with peritoneal metastasis.
Kitayama J; Emoto S; Yamaguchi H; Ishigami H; Kamei T; Yamashita H; Seto Y; Matsuzaki K; Watanabe T
Cytometry B Clin Cytom; 2013 Aug; ():. PubMed ID: 24038963
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometry-based analysis of tumor-leukocyte ratios in peritoneal fluid from patients with advanced gastric cancer.
Takahashi K; Kurashina K; Saito S; Kanamaru R; Ohzawa H; Yamaguchi H; Miyato H; Hosoya Y; Lefor AK; Sata N; Kitayama J
Cytometry B Clin Cytom; 2021 Nov; 100(6):666-675. PubMed ID: 33277773
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T
Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603
[TBL] [Abstract][Full Text] [Related]
6. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal involvement and free tumor cells in peritoneal cavity of patients with colon cancer.
Douard R; Cugnenc PH; Wind P; Bénichou J
Am J Clin Pathol; 2004 Jan; 121(1):154-5; author reply 155. PubMed ID: 14750253
[No Abstract] [Full Text] [Related]
8. Prognostic significance of free peritoneal tumor cells in the peritoneal cavity before and after neoadjuvant chemotherapy in patients with gastric carcinoma undergoing potentially curative resection.
Lorenzen S; Panzram B; Rosenberg R; Nekarda H; Becker K; Schenk U; Höfler H; Siewert JR; Jäger D; Ott K
Ann Surg Oncol; 2010 Oct; 17(10):2733-9. PubMed ID: 20490698
[TBL] [Abstract][Full Text] [Related]
9. [Repeated occlusion of the intraperitoneal access port for intraperitoneal chemotherapy in a patient with gastric cancer with peritoneal dissemination].
Sasaki K; Fujiwara Y; Kishi K; Motoori M; Sugimura K; Miyoshi N; Akita H; Gotoh K; Takahashi H; Marubashi S; Noura S; Ohue M; Yano M; Sakon M; Ishigami H; Kitayama J
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2319-21. PubMed ID: 24394098
[TBL] [Abstract][Full Text] [Related]
10. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Kitayama J; Ishigami H; Yamaguchi H; Yamashita H; Emoto S; Kaisaki S; Watanabe T
Ann Surg Oncol; 2014 Feb; 21(2):539-46. PubMed ID: 23975319
[TBL] [Abstract][Full Text] [Related]
11. Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer.
Takahashi K; Kurashina K; Yamaguchi H; Kanamaru R; Ohzawa H; Miyato H; Saito S; Hosoya Y; Lefor AK; Sata N; Kitayama J
Front Immunol; 2022; 13():969468. PubMed ID: 36119051
[TBL] [Abstract][Full Text] [Related]
12. A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis.
Yamaguchi H; Kitayama J; Ishigami H; Emoto S; Yamashita H; Watanabe T
Cancer; 2013 Sep; 119(18):3354-8. PubMed ID: 23798046
[TBL] [Abstract][Full Text] [Related]
13. Detection of free intraperitoneal tumour cells in peritoneal lavage fluid from patients with peritoneal metastasis before and after treatment with pressurised intraperitoneal aerosol chemotherapy (PIPAC).
Graversen M; Fristrup C; Kristensen TK; Larsen TR; Pfeiffer P; Mortensen MB; Detlefsen S
J Clin Pathol; 2019 May; 72(5):368-372. PubMed ID: 30755498
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization and significance for prognosis of free gastric cancer cells in the peritoneal cavity.
Li C; Ma Y; Xue Y; Zhang H; Wei Y
Hepatogastroenterology; 2009; 56(91-92):891-8. PubMed ID: 19621724
[TBL] [Abstract][Full Text] [Related]
15. Use of peritoneal washing cytology for the detection of free peritoneal cancer cells before and after surgical treatment of gastric adenocarcinoma.
Hasbahceci M; Akcakaya A; Guler B; Kunduz E; Malya FU; Muslumanoglu M
J Cancer Res Ther; 2018; 14(6):1225-1229. PubMed ID: 30488834
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery.
Yonemura Y; Endou Y; Shinbo M; Sasaki T; Hirano M; Mizumoto A; Matsuda T; Takao N; Ichinose M; Mizuno M; Miura M; Ikeda M; Ikeda S; Nakajima G; Yonemura J; Yuuba T; Masuda S; Kimura H; Matsuki N
J Surg Oncol; 2009 Sep; 100(4):311-6. PubMed ID: 19697437
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.
Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Okada K; Mori M; Doki Y
Ann Surg Oncol; 2011 Dec; 18(13):3726-31. PubMed ID: 21584835
[TBL] [Abstract][Full Text] [Related]
18. Feasibility study of S-1 and intraperitoneal docetaxel combination chemotherapy for gastric cancer with peritoneal dissemination.
Fujiwara Y; Nishida T; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Yamamoto K; Moon JH; Mori M; Doki Y
Anticancer Res; 2010 Apr; 30(4):1335-9. PubMed ID: 20530449
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.
Kobayashi D; Kodera Y
Gastric Cancer; 2017 Mar; 20(Suppl 1):111-121. PubMed ID: 27803990
[TBL] [Abstract][Full Text] [Related]
20. Complications and management of an implanted intraperitoneal access port system for intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.
Emoto S; Ishigami H; Hidemura A; Yamaguchi H; Yamashita H; Kitayama J; Watanabe T
Jpn J Clin Oncol; 2012 Nov; 42(11):1013-9. PubMed ID: 22872745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
